lindabill2
About
Subcutaneous tocilizumab in adults along with severe and significant COVID-19: A prospective open-label uncontrolled multicenter tryout.
Subcutaneous tocilizumab in adults along with severe and significant COVID-19: A prospective open-label uncontrolled multicenter tryout.